2007's most comprehensive QT & Safety Pharmacology Strategy Congress takes place in just under two weeks!

Posted:
11
October 2007

The pre-conference workshop will be hosted by Richmond Pharmacology; the leading Trial Centre and ECG Core Lab for conducting QTc studies. The workshop will address 'Key Issues and Best Practice in Conducting a Definitive Thorough QTc Study'.Included in the line up of speakers will be Prof. A. J. Camm, Chairman of the Department of Cardiovascular Sciences and the Division of Cardiological Sciences, St George's Hospital, UK. This offers you the unique opportunity to discuss the latest developments in the design and conduct of QTc studies. Please click the following link to view the agenda for the meeting.As hosts of the QTc Workshop we are pleased to offer the Workshop at a discounted rate to our clients. Alternatively, we are able to also offer both the workshop and main conference for the reduced price of £250. For further information contact Charlotte Vowden at c.vowden@richmondpharmacology.com.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more